Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Marijuana Abuse 3Neoplasms 2Epilepsy 2Tourette Syndrome 1Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1Parkinson Disease 1Pancreatic Cancer Non-resectable 1Pain 1Opioid-Related Disorders 1Neurodevelopmental Disorders 1Multiple Sclerosis 1Marijuana Use 1Inflammatory Bowel Diseases 1Hepatitis C 1Glaucoma 1Fibromyalgia 1Depression 1Crohn Disease 1Coronavirus Infections 1Colitis, Ulcerative 1Chronic Traumatic Encephalopathy 1Chronic Pain 1Carcinoma, Hepatocellular 1COVID-19 1Brain Injuries, Traumatic 1Bipolar Disorder 1Autistic Disorder 1

Interventions

nabiximols 1Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Marijuana Use × Medical Marijuana × Clear all
NCT04827992 2025-11-05

Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

Massachusetts General Hospital

Phase NA Completed
87 enrolled

Marijuana Use, Marijuana Abuse, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡